This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Abbott Laboratories Corporation. Active years: 1992-1995.
Company Filing History:
Years Active: 1992-1995
Title: Innovations of Gregg A Hadley
Introduction
Gregg A Hadley is an accomplished inventor based in St. Louis, MO (US). He has made significant contributions to the field of pharmacology, particularly in the development of assays for phencyclidine and its metabolites. With a total of 2 patents, Hadley's work has advanced the understanding and detection of these compounds.
Latest Patents
Hadley's latest patents focus on a fluorescence polarization assay for phencyclidine and its derivatives. The inventions detail the various components necessary for preparing and conducting such assays, including tracers, immunogens, and antibodies. Specifically, the tracers and immunogens are derived from substituted phencyclidine compounds. A fluorescein moiety is incorporated into the tracer, while a poly(amino acid) is part of the immunogen. The assay measures the degree of polarization retention of plane polarized light that passes through a sample containing antiserum and tracer.
Career Highlights
Gregg A Hadley is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions in drug testing and analysis. His contributions have been instrumental in enhancing the accuracy and efficiency of phencyclidine detection methods.
Collaborations
Hadley has collaborated with notable colleagues, including Robert E Dubler and Mary P Frintner. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Gregg A Hadley is a prominent inventor whose work in the field of pharmacology has led to significant advancements in the detection of phencyclidine and its metabolites. His contributions continue to impact the healthcare industry positively.